AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests

SOUTH SAN FRANCISCO, Calif & BEIJING -- AcornMed Biotechnology Co., Ltd. (AcornMed), a precision medicine organization that specializes in the testing and analysis of solid and blood tumors, announced today that they will incorporate Twist Bioscience next generation sequencing (NGS) target enrichment and library preparation panels into AcornMed’s portfolio of tests designed to provide insight [...]

TetraScience and IDBS Partner to Connect Data in R&D

Boston, MA and Guildford, UK -  TetraScience, the world’s first and only open R&D Data Cloud for scientific discovery, and IDBS, a leading R&D technology and solutions provider, announce a strategic partnership to integrate the IDBS E-Workbook™ and Tetra Data Platform into a common ecosystem to provide end-to-end R&D data automation. This partnership provides seamless connectivity [...]

Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories

SOUTH SAN FRANCISCO, Calif. --  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has signed an agreement enabling multiple academic laboratories at Stanford University to access Twist Bioscience’s innovative antibody discovery and optimization services as well as its unique “Library of [...]

DeepMatter collaborates further with the University of Nottingham

DigitalGlassware ® to be adopted by the University of Nottingham's School of Chemistry to support the development of machine learning models of sustainable chemistry DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, is delighted to be collaborating again with the University of Nottingham's School of Chemistry, providing access to the DigitalGlassware® platform to [...]

Newomics Announces Sales Team and New Kits

Newomics Inc., a biotechnology company developing and commercializing mass spectrometry solutions, today announced that it has established a North America Sales Team, and it is launching a new product to enhance the existing mass spectrometry workflows. Newomics continues its dedication to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. [...]

Vizgen Secures $37M Series B Financing to Advance Spatial Genomics Through Commercialization of MERSCOPE™ Platform

Funding will accelerate company growth and infrastructure expansion leading up to full commercial launch Vizgen, the life science company dedicated to advancing human health by visualizing single-cell spatial genomics information, has closed a $37 million Series B financing. The financing was co-led by Novalis LifeSciences LLC, and current investor Northpond Ventures. Also participating in the round were [...]

CDD AWARDED $1.5M PHASE 2 SBIR GRANT ON AN INTELLIGENT CHEMICAL STRUCTURE BROWSER FOR DRUG DISCOVERY AND OPTIMIZATION

CDD Awarded $1.5M Phase 2 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 2 SBIR grant from NIH NCATS, titled: “Intelligent Chemical Structure Browser for Drug Discovery and Optimization”. This [...]

QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance

QIAseq DIRECT SARS-CoV-2 Kit halves both library preparation times and plasticware use Kit supports analysis of over 6,000 samples simultaneously on highest-throughput sequencers Integrates with QIAGEN Digital Insights cloud solutions to support variant detection and reporting including clade and lineage annotations across sequencing platforms GERMANTOWN, Md. & HILDEN, Germany --  QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime [...]

BIO-TECHNE COMPLETES ACQUISITION OF ASURAGEN, INC.

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.  The transaction included initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones.  The Asuragen acquisition adds a leading portfolio of best-in-class molecular diagnostic and research products, [...]

Captivate Bio Signs Agreement with denovoMATRIX GmbH, Offering Enabling Technologies for Cell Manufacturing

WATERTOWN, Mass.-- Captivate Bio, a scientific cell culture solutions provider headquartered in Watertown, Massachusetts, announced today it has signed a distribution agreement with denovoMATRIX GmbH, a biotechnology company located in Dresden, Germany which designs modular, biomimetic coatings for adherent cell manufacturing. Captivate Bio will become the North American distributor of myMATRIX products including the innovative [...]

Access IBO on Knowledge Center